Accelerate Diagnostics (AXDX) Misses Q1 EPS by 8c

Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• AXIL Brands (AXIL) Tops Q4 EPS by 4c
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance